Previous 10 | Next 10 |
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality have asthma, chronic obstructive pulmonary di...
Tekla Healthcare has a portfolio, consisting of a variety of well-known biotech and pharmaceutical stocks. Tekla Healthcare is currently trading 4% below NAV. The Tekla CEF may hold up well during this bear market due to the nature of its holdings. If you are a little le...
Regeneron’s COVID therapy provided a revenue bolus in 2021. Possible biosimilar competition to Eylea is a concern. Ongoing business, minus the bolus, should continue to be strong to 2025. Regeneron ( REGN ) is a biotech pharmaceutical company best known for th...
Dupixent® (dupilumab) Phase 3 Trial Shows Positive Results in Children 1 to 11 Years of Age with Eosinophilic Esophagitis PR Newswire First and only investigational Phase 3 trial to show positive results in these young children; results follow recent approval of D...
Tekla Life Sciences Investors is a closed-end fund focused on biotechnology and pharmaceutical stocks. The fund does not employ leverage and has an annualized 5-year total return of only 2.3% while its 10-year range annualized return sits at 9.8%. HQL significantly underperforms a...
Ultima Genomics signs development agreement with Regeneron aimed at driving the scale of genomic information for drug discovery and development PR Newswire NEWARK, Calif. , July 12, 2022 /PRNewswire/ -- Ultima Genomics, Inc. (the Company) has signed ...
We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...
Stock splits are big news these days. That's because some of the most popular companies have announced or completed them this year. For example, Amazon split its stock in June. And Tesla shareholders are set to vote on a potential split during their meeting in August. In this ye...
The U.S. Food and Drug Administration (FDA) recently announced that it had accepted Sanofi (NASDAQ: SNY) and Regeneron 's (NASDAQ: REGN) supplemental Biologics License Application for priority review of Dupixent to treat patients with a rare skin disease called prurigo nodul...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any of Tom’s potential 100x picks, subscribe to his mailing list here . Oil Drops Below $10...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...